These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 30718275)

  • 1. Inhibition of the deubiquitinase USP9x induces pre-B cell homeobox 1 (PBX1) degradation and thereby stimulates prostate cancer cell apoptosis.
    Liu Y; Xu X; Lin P; He Y; Zhang Y; Cao B; Zhang Z; Sethi G; Liu J; Zhou X; Mao X
    J Biol Chem; 2019 Mar; 294(12):4572-4582. PubMed ID: 30718275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth.
    Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C
    Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.
    Shang Z; Zhao J; Zhang Q; Cao C; Tian S; Zhang K; Liu L; Shi L; Yu N; Yang S
    J Biol Chem; 2019 Jun; 294(25):9844-9857. PubMed ID: 31073027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WP1130 increases doxorubicin sensitivity in hepatocellular carcinoma cells through usp9x-dependent p53 degradation.
    Liu H; Chen W; Liang C; Chen BW; Zhi X; Zhang S; Zheng X; Bai X; Liang T
    Cancer Lett; 2015 Jun; 361(2):218-25. PubMed ID: 25749422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival.
    Schwickart M; Huang X; Lill JR; Liu J; Ferrando R; French DM; Maecker H; O'Rourke K; Bazan F; Eastham-Anderson J; Yue P; Dornan D; Huang DC; Dixit VM
    Nature; 2010 Jan; 463(7277):103-7. PubMed ID: 20023629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. USP9X stabilizes BRCA1 and confers resistance to DNA-damaging agents in human cancer cells.
    Lu Q; Zhang FL; Lu DY; Shao ZM; Li DQ
    Cancer Med; 2019 Nov; 8(15):6730-6740. PubMed ID: 31512408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. WP1130 attenuates cisplatin resistance by decreasing P53 expression in non-small cell lung carcinomas.
    Wang X; Bao Y; Dong Z; Chen Q; Guo H; Ziang C; Shao J
    Oncotarget; 2017 Jul; 8(30):49033-49043. PubMed ID: 28446729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PBX homeobox 1 enhances hair follicle mesenchymal stem cell proliferation and reprogramming through activation of the AKT/glycogen synthase kinase signaling pathway and suppression of apoptosis.
    Jiang Y; Liu F; Zou F; Zhang Y; Wang B; Zhang Y; Lian A; Han X; Liu Z; Liu X; Jin M; Wang D; Li G; Liu J
    Stem Cell Res Ther; 2019 Aug; 10(1):268. PubMed ID: 31443676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a USP9X Substrate NFX1-123 by SILAC-Based Quantitative Proteomics.
    Chen X; Lu D; Gao J; Zhu H; Zhou Y; Gao D; Zhou H
    J Proteome Res; 2019 Jun; 18(6):2654-2665. PubMed ID: 31059266
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deubiquitinase inhibition by small-molecule WP1130 triggers aggresome formation and tumor cell apoptosis.
    Kapuria V; Peterson LF; Fang D; Bornmann WG; Talpaz M; Donato NJ
    Cancer Res; 2010 Nov; 70(22):9265-76. PubMed ID: 21045142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deubiquitinase ubiquitin-specific protease 9X regulates the stability and function of E3 ubiquitin ligase ring finger protein 115 in breast cancer cells.
    Lu Q; Lu D; Shao ZM; Li DQ
    Cancer Sci; 2019 Apr; 110(4):1268-1278. PubMed ID: 30689267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apigenin manipulates the ubiquitin-proteasome system to rescue estrogen receptor-β from degradation and induce apoptosis in prostate cancer cells.
    Singh V; Sharma V; Verma V; Pandey D; Yadav SK; Maikhuri JP; Gupta G
    Eur J Nutr; 2015 Dec; 54(8):1255-67. PubMed ID: 25408199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. β-catenin is regulated by USP9x and mediates resistance to TRAIL-induced apoptosis in breast cancer.
    Ouyang W; Zhang S; Yang B; Yang C; Zhang J; Zhou F; Xie C
    Oncol Rep; 2016 Feb; 35(2):717-24. PubMed ID: 26717875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Deubiquitylating enzyme USP9x regulates radiosensitivity in glioblastoma cells by Mcl-1-dependent and -independent mechanisms.
    Wolfsperger F; Hogh-Binder SA; Schittenhelm J; Psaras T; Ritter V; Bornes L; Huber SM; Jendrossek V; Rudner J
    Cell Death Dis; 2016 Jan; 7(1):e2039. PubMed ID: 26775694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deubiquitinase USP9x confers radioresistance through stabilization of Mcl-1.
    Trivigno D; Essmann F; Huber SM; Rudner J
    Neoplasia; 2012 Oct; 14(10):893-904. PubMed ID: 23097624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting of the deubiquitinase USP9X attenuates B-cell acute lymphoblastic leukemia cell survival and overcomes glucocorticoid resistance.
    Zhou M; Wang T; Lai H; Zhao X; Yu Q; Zhou J; Yang Y
    Biochem Biophys Res Commun; 2015 Apr; 459(2):333-339. PubMed ID: 25735983
    [TBL] [Abstract][Full Text] [Related]  

  • 17. USP9X stabilizes XIAP to regulate mitotic cell death and chemoresistance in aggressive B-cell lymphoma.
    Engel K; Rudelius M; Slawska J; Jacobs L; Ahangarian Abhari B; Altmann B; Kurutz J; Rathakrishnan A; Fernández-Sáiz V; Brunner A; Targosz BS; Loewecke F; Gloeckner CJ; Ueffing M; Fulda S; Pfreundschuh M; Trümper L; Klapper W; Keller U; Jost PJ; Rosenwald A; Peschel C; Bassermann F
    EMBO Mol Med; 2016 Aug; 8(8):851-62. PubMed ID: 27317434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of USP9X induces apoptosis in FLT3-ITD-positive AML cells cooperatively by inhibiting the mutant kinase through aggresomal translocation and inducing oxidative stress.
    Akiyama H; Umezawa Y; Ishida S; Okada K; Nogami A; Miura O
    Cancer Lett; 2019 Jul; 453():84-94. PubMed ID: 30946869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of the oncogenic transcription factor ERG by deubiquitinase inhibition in prostate cancer.
    Wang S; Kollipara RK; Srivastava N; Li R; Ravindranathan P; Hernandez E; Freeman E; Humphries CG; Kapur P; Lotan Y; Fazli L; Gleave ME; Plymate SR; Raj GV; Hsieh JT; Kittler R
    Proc Natl Acad Sci U S A; 2014 Mar; 111(11):4251-6. PubMed ID: 24591637
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteasome-associated deubiquitinase ubiquitin-specific protease 14 regulates prostate cancer proliferation by deubiquitinating and stabilizing androgen receptor.
    Liao Y; Liu N; Hua X; Cai J; Xia X; Wang X; Huang H; Liu J
    Cell Death Dis; 2017 Feb; 8(2):e2585. PubMed ID: 28151478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.